MOH — authorised 22 June 1998
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
MOH authorised Priftin on 22 June 1998
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 22 June 1998.
SANOFI AVENTIS US holds the Israeli marketing authorisation.